Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation

医学 心房颤动 导管消融 随机对照试验 内科学 肺静脉 药物治疗 冲程(发动机) 生活质量(医疗保健) 烧蚀 心脏病学 窦性心律 机械工程 工程类 护理部
作者
Daniel B. Mark,Kevin J. Anstrom,Shubin Sheng,Jonathan P. Piccini,Khaula Baloch,Kristi H. Monahan,Melanie R. Daniels,Tristram D. Bahnson,Jeanne E. Poole,Yves Rosenberg,Kerry L. Lee,Douglas L. Packer
出处
期刊:JAMA [American Medical Association]
卷期号:321 (13): 1275-1275 被引量:541
标识
DOI:10.1001/jama.2019.0692
摘要

Importance

Catheter ablation is more effective than drug therapy in restoring sinus rhythm in patients with atrial fibrillation (AF), but its incremental effect on long-term quality of life (QOL) is uncertain.

Objective

To determine whether catheter ablation is more beneficial than conventional drug therapy for improving QOL in patients with AF.

Design, Setting, and Participants

An open-label randomized clinical trial of catheter ablation vs drug therapy in 2204 symptomatic patients with AF older than 65 years or 65 years or younger with at least 1 risk factor for stroke. Patients were enrolled from November 2009 to April 2016 from 126 centers in 10 countries. Follow-up ended in December 2017.

Interventions

Pulmonary vein isolation, with additional ablation procedures at the discretion of the investigators, for the catheter ablation group (n = 1108) and standard rhythm and/or rate-control drugs selected and managed by investigators for the drug therapy group (n = 1096).

Main Outcomes and Measures

Prespecified co-primary QOL end points at 12 months, including the Atrial Fibrillation Effect on Quality of Life (AFEQT) summary score (range, 0-100; 0 indicates complete disability and 100 indicates no disability; patient-level clinically important difference, ≥5 points) and the Mayo AF-Specific Symptom Inventory (MAFSI) frequency score (range, 0-40; 0 indicates no symptoms and 40 indicates the most severe symptoms; patient-level clinically important difference, ≤−1.6 points) and severity score (range, 0-30; 0 indicates no symptoms and 30 indicates the most severe symptoms; patient-level clinically important difference, ≤−1.3 points).

Results

Among 2204 randomized patients (median age, 68 years; 1385 patients [63%] were men, 946 [43%] had paroxysmal AF, and 1256 [57%] had persistent AF), the median follow-up was 48.5 months, and 1968 (89%) completed the trial. The mean AFEQT summary score was more favorable in the catheter ablation group than the drug therapy group at 12 months (86.4 points vs 80.9 points) (adjusted difference, 5.3 points [95% CI, 3.7-6.9];P < .001). The mean MAFSI frequency score was more favorable for the catheter ablation group than the drug therapy group at 12 months (6.4 points vs 8.1 points) (adjusted difference, −1.7 points [95% CI, −2.3 to −1.2];P < .001) and the mean MAFSI severity score was more favorable for the catheter ablation group than the drug therapy group at 12 months (5.0 points vs 6.5 points) (adjusted difference, −1.5 points [95% CI, −2.0 to −1.1];P < .001).

Conclusions and Relevance

Among patients with symptomatic atrial fibrillation, catheter ablation, compared with medical therapy, led to clinically important and significant improvements in quality of life at 12 months. These findings can help guide decisions regarding management of atrial fibrillation.

Trial Registration

ClinicalTrials.gov Identifier:NCT00911508
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
思源的应助被嘻嘻哈哈顺利采纳,获得30
2秒前
zgm完成签到,获得积分10
2秒前
2秒前
王人捷发布了新的文献求助30
4秒前
搜集达人的应助被追寻夏槐采纳,获得20
4秒前
BIGDUCK完成签到,获得积分10
5秒前
FashionBoy的应助被vc采纳,获得10
5秒前
6秒前
7秒前
GG酱发布了新的文献求助30
7秒前
酷波er的应助被眼睛大初之采纳,获得10
8秒前
9秒前
田様的应助被鹦鹉采纳,获得10
9秒前
黄橙橙完成签到 ,获得积分10
10秒前
10秒前
syvshc的应助被含蓄的冰绿采纳,获得10
11秒前
lucky完成签到 ,获得积分10
12秒前
12秒前
13秒前
Ferry完成签到,获得积分10
14秒前
14秒前
JH_Yang发布了新的文献求助10
15秒前
Nole的应助被hannah采纳,获得10
16秒前
zZZZ发布了新的文献求助10
17秒前
17秒前
Ryan发布了新的文献求助10
17秒前
18秒前
西红柿发布了新的文献求助10
18秒前
123发布了新的文献求助10
18秒前
欢呼半山完成签到 ,获得积分10
18秒前
19秒前
19秒前
桐桐的应助被清水烫春菜采纳,获得10
21秒前
Ava的应助被酷酷的悒采纳,获得10
21秒前
21秒前
科研通AI6.2的应助被12采纳,获得10
21秒前
22秒前
23秒前
24秒前
开心小懒虫完成签到,获得积分10
24秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8192776
求助须知:如何正确求助?哪些是违规求助? 9579206
关于积分的说明 21864151
捐赠科研通 7792348
什么是DOI,文献DOI怎么找? 3437041
关于科研通互助平台的介绍 2560633
邀请新用户注册赠送积分活动 2483916